Paper30419600
The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role.
Madunić J. Thromb Haemost, 2018. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role. Papers, record 30419600. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30419600
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Extracellular Matrix | Major topic |
| Fibrinolysin | Major topic |
| Neoplasms | Major topic |
| Urokinase-Type Plasminogen Activator | Major topic |
| Carcinogenesis | |
| Humans | |
| Neoplasm Metastasis | |
| Predictive Value of Tests | |
| Prognosis | |
| Proteolysis | |
| Ubiquitination |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42379802 | Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro. | In Vivo | 2026 | https://conductscience.org/library/papers/42379802 | PubMed |
| 42234219 | Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. | Clin Exp Metastasis | 2026 | https://conductscience.org/library/papers/42234219 | PubMed |
| 41901243 | A Mechanistic Digital Twin of uPAR-Driven Prostate Cancer Invasion Integrating ODE Signalling and Agent-Based Modelling. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901243 | PubMed |
| 41858315 | A contemporary review of plasminogen activator inhibitor 1 in cardiovascular disease and broader disease state implications. | Blood Vessel Thromb Hemost | 2026 | https://conductscience.org/library/papers/41858315 | PubMed |
| 41559139 | From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41559139 | PubMed |
| 39744227 | Optical molecular imaging in oral- and oropharyngeal squamous cell carcinoma using a novel uPAR-targeting near-infrared imaging agent FG001 (ICG-Glu-Glu-AE105): An explorative phase II clinical trial. | Theranostics | 2025 | https://conductscience.org/library/papers/39744227 | PubMed |
| 39678603 | PRKD3 promotes proliferation of liver cancer cells: a downstream proteomics profiling study. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/39678603 | PubMed |
| 38715331 | Endothelial-specific Enhancer as a Cis Element of PLAUR Regulation by TNF-alpha, IL-1beta, and VEGF. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38715331 | PubMed |
| 38275392 | Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma. | Biomedicines | 2023 | https://conductscience.org/library/papers/38275392 | PubMed |
| 38103082 | miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 + cells partially via SERPINE1. | Cell Mol Life Sci | 2023 | https://conductscience.org/library/papers/38103082 | PubMed |
| 36942151 | Fibrinolysis: an illustrated review. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/36942151 | PubMed |
| 36598826 | The roles of proteases in prostate cancer. | IUBMB Life | 2023 | https://conductscience.org/library/papers/36598826 | PubMed |
| 36415513 | Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | https://conductscience.org/library/papers/36415513 | PubMed |
| 36124441 | Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study. | Biomol Biomed | 2023 | https://conductscience.org/library/papers/36124441 | PubMed |
| 35775375 | Expression patterns of uPAR, TF and EGFR and their potential as targets for molecular imaging in oropharyngeal squamous cell carcinoma. | Oncol Rep | 2022 | https://conductscience.org/library/papers/35775375 | PubMed |
| 35480116 | Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/35480116 | PubMed |
| 35303878 | Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer. | J Transl Med | 2022 | https://conductscience.org/library/papers/35303878 | PubMed |
| 35087738 | Prognostic Significance and Gene Co-Expression Network of PLAU and PLAUR in Gliomas. | Front Oncol | 2021 | https://conductscience.org/library/papers/35087738 | PubMed |
| 34771541 | The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771541 | PubMed |
| 34732728 | Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression. | Nat Commun | 2021 | https://conductscience.org/library/papers/34732728 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PLAU | 5328 | PubTator's text mining | https://conductscience.org/library/genes/5328 | NCBI Gene |
| PLAUR | 5329 | PubTator's text mining | https://conductscience.org/library/genes/5329 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINE1 | 5054 | PubTator's text mining | https://conductscience.org/library/genes/5054 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30419600
GET https://conductscience.org/api/papers/v1/30419600/cited_by?page=2